Abstract
Despite MYC dysregulation in most human cancers, strategies to target this potent oncogenic driver remain an urgent unmet need. Recent evidence shows the PP1 phosphatase and its regulatory subunit PNUTS control MYC phosphorylation, chromatin occupancy, and stability, however the molecular basis remains unclear. Here we demonstrate that MYC interacts directly with PNUTS through the MYC homology Box 0 (MB0), a highly conserved region recently shown to be important for MYC oncogenic activity. By NMR we identified a distinct peptide motif within MB0 that interacts with PNUTS residues 1–148, a functional unit, here termed PNUTS amino-terminal domain (PAD). Using NMR spectroscopy we determined the solution structure of PAD, and characterised its MYC-binding patch. Point mutations of residues at the MYC-PNUTS interface significantly weaken their interaction both in vitro and in vivo, leading to elevated MYC phosphorylation. These data demonstrate that the MB0 region of MYC directly interacts with the PAD of PNUTS, which provides new insight into the control mechanisms of MYC as a regulator of gene transcription and a pervasive cancer driver.
All Related Versions
Funding Information
  • Canadian Institutes of Health Research (FRN156167, FDN154328, FDN143312)
  • Swedish Cancer Society (20 1276 PjF 01 H)
  • Swedish Childhood Cancer Foundation (PR2019-0143, TJ2018-0103)
  • Swedish Research Council (2018-04390, 2016-05369)
  • Princess Margaret Cancer Centre
  • Princess Margaret Cancer Foundation
  • Ontario Ministry of Health (1097737)
  • Bayer AG
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Genentech
  • Genome Canada (OGI-196, 875510)
  • Janssen
  • Merck KGaA
  • Pfizer
  • Takeda
  • Linköping University
  • Swedish National Infrastructure for Computing
  • National Supercomputer Centre

This publication has 75 references indexed in Scilit: